Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Russian Move To Limit Medtech Imports Could Harm Domestic Innovation

This article was originally published in Clinica

Executive Summary

Import substitution and tendering practices that put non-Russian/EAEU-based medtech manufacturers at a disadvantage were introduced under Russian Resolution 102 in February 2015. Clinica asked executives from IMEDA, Russia’s International Medical Device Manufacturers Association, what effect this will have on market supply, patient care and innovation


Related Content

Russia's Medtech Looks For Chain Reaction After Philips Partnership Deal